Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Protoc ; 3(6): e792, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37283517

ABSTRACT

Our group has developed several approaches for stable, non-viral integration of inducible transgenic elements into the genome of mammalian cells. Specifically, a piggyBac tetracycline-inducible genetic element of interest (pB-tet-GOI) plasmid system allows for stable piggyBac transposition-mediated integration into cells, identification of cells that have been transfected using a fluorescent nuclear reporter, and robust transgene activation or suppression upon the addition of doxycycline (dox) to the cell culture or the diet of the animal. Furthermore, the addition of luciferase downstream of the target gene allows for quantitative assessment of gene activity in a non-invasive manner. More recently, we have developed a transgenic system as an alternative to piggyBac called mosaic analysis by dual recombinase-mediated cassette exchange (MADR), as well as additional in vitro transfection techniques and in vivo dox chow applications. The protocols herein provide instructions for the use of this system in cell lines and in the neonatal mouse brain. © 2023 Wiley Periodicals LLC. Basic Protocol 1: Cloning of respective genetic element of interest (GOI) into response plasmid Basic Protocol 2: In vitro nucleofection of iPSC-derived human/mouse neural progenitor cells and subsequent derivation of stable inducible cell lines Alternate Protocol: In vitro electroporation of iPSC-derived human/mouse neural progenitor cells Support Protocol: Recovery stage after in vitro transfection Basic Protocol 3: Adding doxycycline to cells to induce/reverse GOI Basic Protocol 4: Assessing gene expression in vitro by non-invasive bioluminescence imaging of luciferase activity.


Subject(s)
Doxycycline , Induced Pluripotent Stem Cells , Humans , Animals , Mice , Doxycycline/pharmacology , Doxycycline/metabolism , Induced Pluripotent Stem Cells/metabolism , Genes, Reporter , Genetic Vectors , DNA Transposable Elements , Anti-Bacterial Agents/metabolism , Tetracycline/pharmacology , Tetracycline/metabolism , Luciferases/genetics , Luciferases/metabolism , Gene Expression , Brain , Mammals/genetics , Mammals/metabolism
2.
Cell ; 179(1): 251-267.e24, 2019 09 19.
Article in English | MEDLINE | ID: mdl-31539496

ABSTRACT

In situ transgenesis methods such as viruses and electroporation can rapidly create somatic transgenic mice but lack control over copy number, zygosity, and locus specificity. Here we establish mosaic analysis by dual recombinase-mediated cassette exchange (MADR), which permits stable labeling of mutant cells expressing transgenic elements from precisely defined chromosomal loci. We provide a toolkit of MADR elements for combination labeling, inducible and reversible transgene manipulation, VCre recombinase expression, and transgenesis of human cells. Further, we demonstrate the versatility of MADR by creating glioma models with mixed reporter-identified zygosity or with "personalized" driver mutations from pediatric glioma. MADR is extensible to thousands of existing mouse lines, providing a flexible platform to democratize the generation of somatic mosaic mice. VIDEO ABSTRACT.


Subject(s)
Brain Neoplasms/genetics , Disease Models, Animal , Gene Targeting/methods , Genetic Loci/genetics , Glioma/genetics , Mutagenesis, Insertional/methods , Transgenes/genetics , Animals , Cell Line, Tumor , Female , HEK293 Cells , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neural Stem Cells/metabolism , Recombinases/metabolism , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...